The Future of Physiologically Based Pharmacokinetic Modeling to Predict Drug Exposure in Pregnant Women

被引：7
|
作者：
Vinks, A. A. [1 ,2 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Dept Clin Pharmacol, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
来源：
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY | 2013年 / 2卷 / 03期
关键词：
D O I：
10.1038/psp.2013.9
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Pregnant women have long been orphaned from drug studies. The application of physiologically based pharmacokinetic modeling to quantitatively describe drug disposition and effects during pregnancy is an attractive approach that is now actively pursued as it allows optimal use of available information for both efficient study designs and prediction of maternal-fetal exposure.
引用
收藏
页数：3
相关论文
共 50 条
  • [41] A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways
    André Dallmann
    Ibrahim Ince
    Katrin Coboeken
    Thomas Eissing
    Georg Hempel
    Clinical Pharmacokinetics, 2018, 57 : 749 - 768
  • [42] Physiologically based pharmacokinetic modeling of apixaban to predict exposure in populations with hepatic and renal impairment and elderly populations
    Yichao Xu
    Lei Zhang
    Xiaofan Dou
    Yongze Dong
    Xiangchai Guo
    European Journal of Clinical Pharmacology, 2024, 80 : 261 - 271
  • [43] Physiologically based pharmacokinetic modeling of apixaban to predict exposure in populations with hepatic and renal impairment and elderly populations
    Xu, Yichao
    Zhang, Lei
    Dou, Xiaofan
    Dong, Yongze
    Guo, Xiangchai
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (02) : 261 - 271
  • [44] Physiologically-based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors
    Ueno, Takashi
    Miyajima, Yukiko
    Landry, Ishani
    Lalovic, Bojan
    Schuck, Edgar
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (05): : 455 - 466
  • [45] Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development
    Maharaj, A. R.
    Edginton, A. N.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2014, 3 (11):
  • [46] Physiologically Based Pharmacokinetic Modeling in Pediatric Oncology Drug Development
    Rioux, Nathalie
    Waters, Nigel J.
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (07) : 934 - 943
  • [47] Physiologically based pharmacokinetic modeling as a tool for drug development - Commentary
    Ludden, TM
    Gillespie, WR
    Bachman, WJ
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1995, 23 (02): : 231 - 235
  • [48] Opportunities and challenges of physiologically based pharmacokinetic modeling in drug delivery
    Wang, Wei
    Ouyang, Defang
    DRUG DISCOVERY TODAY, 2022, 27 (08) : 2100 - 2120
  • [49] Impact of Physiologically Based Pharmacokinetic Modeling and Simulation in Drug Development
    Shardlow, Carole E.
    Generaux, Grant T.
    Patel, Aarti H.
    Tai, Guoying
    Thuy Tran
    Bloomer, Jackie C.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 1994 - 2003
  • [50] A review of physiologically based pharmacokinetic modeling of renal drug disposition
    Huang, Weize
    Bowman, Christine
    Yin, Mengyue
    Han, Lyrialle W.
    Wen, Yue Winnie
    Ahn, Sara Kim
    Chen, Yuan
    DRUG METABOLISM AND DISPOSITION, 2025, 53 (03)
12345